Regulation of SYSTEMIC INSULIN SENSITIVITY by miRNA-30a

miRNA-30a 对全身胰岛素敏感性的调节

基本信息

  • 批准号:
    9111200
  • 负责人:
  • 金额:
    $ 7.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-04-01 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Insulin resistance and type 2 diabetes are predicted to affect 33% of the US population by 2050. Type 2 diabetes reflects the inability to store surplus energy derived from calories in fat cells. Obese fat displays a pro-inflammatory phenotype, which is partly responsible for the metabolic dysfunction and insulin resistance that precedes type 2 diabetes. Recent work challenges the idea that the all immune response is deleterious to adipose tissue. In particular, regulatory T cells (Tregs) counteract the proinflammatory response in adipose tissue to potentiate insulin sensitivity. We have discovered that overexpression of the microRNA miR-30a in subcutaneous adipose tissue of diabetic mice promotes insulin sensitivity. Through the use of RNA-seq and flow cytometry, we observed that the metabolic effects of miR-30a overexpression in subcutaneous adipose tissue are associated with increased recruitment of Tregs, which suppress local inflammation. In addition, we found that expression of miR-30a and the master controller of Treg function, Foxp3, are reduced in subcutaneous adipose tissue from insulin resistant compared to insulin sensitive human subjects. We hypothesize miR-30a promotes insulin sensitivity by stimulating the function of Tregs in subcutaneous adipose tissue. Two specific aims are proposed to critically test our hypothesis: (1) determine the role of Tregs in mediating anti-diabetic effects of miR-30a; (2) determine how miR-30a affects Treg polarization. The rationale for the proposed research plan is that identifying the mechanism underlying the beneficial effects of miR-30a expression in subcutaneous adipose tissue will lead to therapeutic strategies to enhance metabolic flexibility in subcutaneous adipocytes and thereby prevent type 2 diabetes. If our hypothesis is true, miR-30a might be exploited in novel therapies to manage insulin resistance and type 2 diabetes. We anticipate that our studies will provide new clues into the complex regulatory networks controlling energy balance in subcutaneous adipose tissue.
 描述(由申请人提供):预计到2050年,胰岛素抵抗和2型糖尿病将影响33%的美国人口。2型糖尿病反映了无法将来自卡路里的多余能量储存在脂肪细胞中。肥胖脂肪显示出促炎表型,这是2型糖尿病之前的代谢功能障碍和胰岛素抵抗的部分原因。最近的工作挑战了全免疫反应对脂肪组织有害的观点。特别地,调节性T细胞(Tcells)抵消脂肪组织中的促炎反应以增强胰岛素敏感性。我们已经发现,在糖尿病小鼠皮下脂肪组织中microRNA miR-30 a的过表达促进胰岛素敏感性。通过使用RNA-seq和流式细胞术,我们观察到皮下脂肪组织中miR-30 a过表达的代谢效应与TGFAP的募集增加相关,TGFAP抑制局部炎症。此外,我们发现,与胰岛素敏感的人类受试者相比,胰岛素抵抗的皮下脂肪组织中miR-30 a和Treg功能的主控制器Foxp 3的表达减少。我们假设miR-30 a通过刺激皮下脂肪组织中TGFAP的功能来促进胰岛素敏感性。提出了两个具体的目标来严格检验我们的假设:(1)确定TcG在介导miR-30 a的抗糖尿病作用中的作用;(2)确定miR-30 a如何影响Treg极化。拟议研究计划的基本原理是,确定皮下脂肪组织中miR-30 a表达的有益作用的机制将导致治疗策略,以增强皮下脂肪细胞的代谢灵活性,从而预防2型糖尿病。如果我们的假设是正确的,那么miR-30 a可能会被用于治疗胰岛素抵抗和2型糖尿病的新疗法。我们期望我们的研究将为控制皮下脂肪组织能量平衡的复杂调控网络提供新的线索。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sean Hartig其他文献

Sean Hartig的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sean Hartig', 18)}}的其他基金

METABOLIC IMPACTS OF TYPE II INTERFERON SIGNALS IN OBESITY
II 型干扰素信号对肥胖的代谢影响
  • 批准号:
    10775353
  • 财政年份:
    2023
  • 资助金额:
    $ 7.93万
  • 项目类别:
An anti-diabetic microRNA that promotes metabolically healthy obesity
一种抗糖尿病 microRNA,可促进代谢健康的肥胖
  • 批准号:
    9367450
  • 财政年份:
    2017
  • 资助金额:
    $ 7.93万
  • 项目类别:
Metabolic Impacts of Type II Interferon Signals in Obesity
II 型干扰素信号对肥胖的代谢影响
  • 批准号:
    10665744
  • 财政年份:
    2017
  • 资助金额:
    $ 7.93万
  • 项目类别:
An anti-diabetic microRNA that promotes metabolically healthy obesity
一种抗糖尿病的 microRNA,可促进代谢健康的肥胖
  • 批准号:
    10163161
  • 财政年份:
    2017
  • 资助金额:
    $ 7.93万
  • 项目类别:
Metabolic Impacts of Type II Interferon Signals in Obesity
II 型干扰素信号对肥胖的代谢影响
  • 批准号:
    10900013
  • 财政年份:
    2017
  • 资助金额:
    $ 7.93万
  • 项目类别:
Regulation of SYSTEMIC INSULIN SENSITIVITY by miRNA-30a
miRNA-30a 对全身胰岛素敏感性的调节
  • 批准号:
    9217647
  • 财政年份:
    2016
  • 资助金额:
    $ 7.93万
  • 项目类别:
A novel axis regulates adipocyte plasticity
调节脂肪细胞可塑性的新轴
  • 批准号:
    8787734
  • 财政年份:
    2013
  • 资助金额:
    $ 7.93万
  • 项目类别:
A novel axis regulates adipocyte plasticity
调节脂肪细胞可塑性的新轴
  • 批准号:
    8631084
  • 财政年份:
    2013
  • 资助金额:
    $ 7.93万
  • 项目类别:
A novel axis regulates adipocyte plasticity
调节脂肪细胞可塑性的新轴
  • 批准号:
    8508348
  • 财政年份:
    2013
  • 资助金额:
    $ 7.93万
  • 项目类别:
Unique Roles of p160 Coactivators during Human Adipogenesis
p160 共激活剂在人类脂肪形成过程中的独特作用
  • 批准号:
    7804266
  • 财政年份:
    2009
  • 资助金额:
    $ 7.93万
  • 项目类别:

相似国自然基金

相似海外基金

Recruitment of brown adipocytes in visceral white adipose tissue by fibroblast growth factor 8b
成纤维细胞生长因子 8b 将棕色脂肪细胞募集到内脏白色脂肪组织中
  • 批准号:
    321208980
  • 财政年份:
    2016
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Research Grants
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8827438
  • 财政年份:
    2014
  • 资助金额:
    $ 7.93万
  • 项目类别:
Induction of brown-like adipocytes in white adipose tissue by food-derived factors
食物源性因子在白色脂肪组织中诱导棕色样脂肪细胞
  • 批准号:
    26450168
  • 财政年份:
    2014
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
WAT-on-a-chip - Development of a micofluidic, microphysiologic in vitro adipose tissue model for high-throughput drug screening based on hiPSC-derived adipocytes.
WAT-on-a-chip - 开发微流体、微生理体外脂肪组织模型,用于基于 hiPSC 衍生脂肪细胞的高通量药物筛选。
  • 批准号:
    257256526
  • 财政年份:
    2014
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Research Fellowships
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8828181
  • 财政年份:
    2013
  • 资助金额:
    $ 7.93万
  • 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8520690
  • 财政年份:
    2013
  • 资助金额:
    $ 7.93万
  • 项目类别:
Enhancing Energy Expending Adipocytes in White Adipose Tissue
增强白色脂肪组织中的能量消耗脂肪细胞
  • 批准号:
    8629741
  • 财政年份:
    2013
  • 资助金额:
    $ 7.93万
  • 项目类别:
Effect of exercise training on formation of brite adipocytes within white adipose tissue
运动训练对白色脂肪组织内脂肪细胞形成的影响
  • 批准号:
    23700778
  • 财政年份:
    2011
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Investigation for the mechanisms of the emergence of brown adipocytes in white adipose tissue
白色脂肪组织中棕色脂肪细胞出现机制的研究
  • 批准号:
    21780261
  • 财政年份:
    2009
  • 资助金额:
    $ 7.93万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
LOUISIANA COBRE: P1: INDUCE THERMOGENIC BROWN ADIPOCYTES IN WHITE ADIPOSE TISSUE
路易斯安那 COBRE:P1:在白色脂肪组织中诱导产热棕色脂肪细胞
  • 批准号:
    7610781
  • 财政年份:
    2007
  • 资助金额:
    $ 7.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了